Management of constipation in palliative care patients

Current Opinion in Supportive and Palliative Care

Volumn 2, Issue 1, 2008, Pages 22-27

  Clemens, Katri Elina ^a,b   Klaschik, Eberhard ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b Malteser Hospital Bonn/Rhein Sieg   (Germany)

Author keywords

Constipation; Laxative; Opioids; Palliative care

Indexed keywords

LAXATIVE; NARCOTIC ANALGESIC AGENT;

CHEMICALLY INDUCED DISORDER; CONSTIPATION; HUMAN; METHODOLOGY; NEOPLASM; PAIN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; REVIEW;

ANALGESICS, OPIOID; CONSTIPATION; HUMANS; LAXATIVES; NEOPLASMS; PAIN; PALLIATIVE CARE;

EID: 56149115267     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e3282f53146     Document Type: Review

References (25)

1. Mancini I, Bruera E. Constipation in advanced cancer patients. Support Care Cancer 1998; 6:356-364.
2. Vainio A, Auvinen A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage 1996; 12:3-10.
3. Fallon MT. Constipation in cancer patients: prevalence, pathogenesis, and cost-related issues. Eur J Pain 1999; 3 (suppl):3-7.
4. McMillan SC. Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control 2004; 11 (3 suppl):3-9.
5. Avila JG. Pharmacologic treatment of constipation in cancer patients. Cancer Control 2004; 11 (3 suppl):10-18.
6. Goodman ML, Wilkinson S. Laxatives for the management of constipation in palliative care patients. Cochrane Library 2004; 4:1 -11.
7. Goodman M, Low J, Wilkinson S. Constipation management in palliative care: a survey of practices in the United Kingdom. J Pain Symptom Manage 2005; 29:238-244.
8. McNicol E, Horowitcz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003; 4:231 -256.
9. Bruera E, Suarez-Almazor M, Velasco A, et al. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symptom Manage 1994; 9:515-519.
10. Sykes N. The current management of constipation in palliative care. Prog Palliat Care 1996; 4:170-177.
11. Scottish Intercollegiate Guidelines Network. Control of pain in patients with cancer 2000 (SIGN publ. no. 44). Edinburgh: Scottish Intercollegiate Guidelines Network; 2000.
12. Mancini I, Bruera E. Constipation. In: Ripamonti C, Bruera E, editors. Gastrointestinal symptoms in advanced cancer patients. New York: Oxford university Press; 2002. pp. 193-206.
13. Chang L. From Rome to LosAngeles - The Rome III Criteria for the Functional GI Disorders. Gastroenterology 2006; 130:1480-1491. This article presents the new Rome III criteria. Also included are some of the differences between Rome II and Rome III criteria as well as the rationale for publishing this new version. The publication delivers essential information for clinical practice.
14. Fallon MT, Hanks GW. Morphine, constipation and performance status in advanced cancer patients. Palliat Med 1999; 13:159-160.
15. Stewart WF, Libermann JN, Sandler RS, et al. Epidemiology of constipation (EPOC) Study in the United States: relation of clinical subtypes to socioconomic features. Am J Gastroenterol 1999; 94:3530-3539.
16. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000; 8:175-179.
17. Kaufman PN, Krevesky B, Malmud LS, et al. Role of opiate receptors in the regulation of colonic transit. Gastroenterology 1998; 94:1351 - 1356.
18. Sykes N. The treatment of morphine induced constipation. Eur J Palliat Care 1998; 5:12-15.
19. DiPalma J. Current treatment options for chronic constipation. Rev Gastroenterol Disord 2004; 2 Suppl:34-42.
20. Jurna I, Baldauf J. Prolonged release by oral naloxone: neutralisation of the obstruction using oral morphine without loss of pain relief [in German]. Der Schmerz 1993; 7:314-321.
21. Meissner W, Schmidt U, Hartmann M, et al. Oral naloxone reverses opioid- associated constipation. Pain 2000; 84:105-109.
22. Shaiova L, Rim F, Friedman D, Jahdi M. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation. Palliat Support Care 2007; 5:161 -166. This article reviews existing clinical data, focusing on antagonism of opioidinduced adverse effects on the gastrointestinal system and shows that methylnaltrexone seems to be well tolerated with limited or transient side effects.
23. Wanitschke R, Goerg KJ, Loew D. Differential therapy of constipation - a review. Int J Clin Pharmacol Ther 2003; 41:14-21.
24. Miles CL, Fellows D, Goodman ML, Wilkinson S. Laxatives for the management of constipation in palliative care patients. Cochrane Database Syst Rev 2006; 4:CD003448. This Cochrane review aims at determining the effectiveness of laxative administration for the management of constipation in palliative care patients and the differential efficacy of the laxatives used to manage constipation in the light of varying recommendations for 'best management'.
25. Clemens KE, Klaschik E. Managing nausea, emesis, and constipation in palliative care. Dtsch Arztebl 2007; 104:269-279